Tic disorders: New developments in Tourette syndrome and related disorders

Current Opinion in Neurology

Volumn 11, Issue 4, 1998, Pages 373-380

  Robertson, Mary M ^a   Stern, Jeremy S ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; CLOZAPINE; DEXAMPHETAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; GUANFACINE; HALOPERIDOL; METHYLPHENIDATE; OLANZAPINE; PERGOLIDE; PIMOZIDE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTINDOLE; SULPIRIDE; TETRABENAZINE;

ATTENTION DEFICIT DISORDER; AUTOIMMUNITY; COMORBIDITY; DEPRESSION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GILLES DE LA TOURETTE SYNDROME; HUMAN; NEUROBIOLOGY; NEUROIMMUNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSION; POSITRON EMISSION TOMOGRAPHY; PSYCHOSURGERY; REVIEW; SIDE EFFECT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TIC;

BRAIN; COMBINED MODALITY THERAPY; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HUMANS; PREVALENCE; RANDOMIZED CONTROLLED TRIALS; TOURETTE SYNDROME;

EID: 0031667834     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199808000-00014     Document Type: Review

References (94)

1. Rickards H, Robertson MM. Vomiting and retching in Gilles de la Tourette syndrome: a report of 10 cases and a review of the literature. Mov Disord 1997; 12:531-535.
2. Wilson NW, Jaynes M, Gingold M, Hogan MB. Tourette's syndrome mimicking asthma and chronic cough. J Allergy Clin Immunol 1998; 101:479.
3. Kim H, Moote W, Mazza J. Tourette's syndrome in patients referred for allergy evaluation. Ann Allergy Asthma Immunol 1997; 79:347-349.
4. Pauls DL, Leckman JF, Cohen DJ. Evidence against a genetic relationship between Tourette's syndrome and anxiety, depression, panic and phobic disorders. Br J Psychiatry 1994; 164:215-221.
5. 2 receptor gene with Tourette syndrome and a variety of other psychopathologies.
6. Kurlan R. Diagnostic criteria for genetic studies of Tourette syndrome [letter]. Arch Neurol 1997; 54:517-518. A discussion of the importance of phenotype definition in genetic studies with a suggested guideline.
7. Eapen V, Robertson MM, Zeitlin H, Kurlan R. Gilles de la Tourette's syndrome in special education schools: a United Kingdom study. J Neurol 1997; 244:378-382.
8. Mason A, Banerjee S, Eapen V, Zeitlin H, Robertson MM. The prevalence of Gilles de la Tourette's syndrome in a mainstream school population. Dev Med Child Neurol 1998; 4:292-296.
9. Staley D, Wand R, Shady G. Tourette disorder: a cross cultural review. Compr Psychiatry 1997; 38:6-16.
10. Chee K-Y, Sachdev P. A controlled study of sensory tics in Gilles de la Tourette syndrome and obsessive-compulsive disorder using a structured interview. J Neurol Neurosurg Psychiatry 1997; 62:188-192.
11. Robertson MM, Banerjee S, Fox Hiley PJ, Tannock C. Personality disorder and psychopathology in Tourette's syndrome: a controlled study. Br J Psychiatry 1997, 171:283-286. A study of 39 adults with Tourette syndrome from a clinic population showing high rates of personality disorder and depression.
12. Zohar AH, Pauls DL, Ratzoni G, Apter A, Dycian A, Binder M, et al. Obsessive-compulsive disorder with and without tics in an epidemiological sample of adolescents. Am J Psychiat 1997; 154:274-276. A population study of obsessive-compulsive spectrum disorders in adolescents delineating the features seen in ascertained cases with and without tics. Those with tics were more prone to aggressive and sexual obsessions.
13. Miguel EC, Baer L, Coffey BJ, Rauch SL, Savage CR, O'Sullivan RL, et al. Phenomenological differences appearing with repetitive behaviours in obsessive-compulsive disorder and Gilles de la Tourette syndrome. Br J Psychiatry 1997; 170:140-145.
14. Muller N, Putz A, Kathman N, Lehle R, Gunther W, Straube A. Characteristics of obsessive-compulsive symptoms in Tourette's syndrome, obsessive-compulsive disorder and Parkinson's disease. Psychiatry Res 1997; 70:105-114.
15. Eapen V, Robertson MM, Alsobrook JP, Pauls DL. Obsessive compulsive symptoms in Gilles de la Tourette syndrome and obsessive compulsive disorder: differences by diagnosis and family history. Am J Med Genet 1997; 74:432-438. One of several publications showing a specific pattern of obsessionality in clinic cases of Tourette syndrome compared with pure OCD; the authors discuss the implications for possible heterogeneity in pure OCD in cases in which patients display a Tourette syndrome pattern.
16. Geller DA, Biederman J, Jones J, Shapiro S, Schwartz S, Park KS. Obsessive-compulsive disorders in children and adolescents: a review. Harvard Rev Psychiatry 1998; 5:260-273.
17. Wodrich DL, Benjamin E, Lachar D. Tourette's syndrome and psychopathology in a child psychiatry setting. J Am Acad Child Adolesc Psychiatry 1997; 36:1618-1624.
18. Berthier ML, Kulisevsky J, Campos VM. Bipolar disorder in adult patients with Tourette's syndrome: a clinical study. Biol Psychiatry 1998; 43:364-370.
19. Kerbeshian J, Burd L, Klug MG. Comorbid Tourette's disorder and bipolar disorder: an etiologic perspective. Am J Psychiatry 1995; 152:1646-1651.
20. Leckman JF, Dolansky ES, Hardin MT. Perinatal factors in the expression of Tourette's syndrome: an exploratory study. J Am Acad Child Adolesc Psychiatry 1990, 29:220-226.
21. Alsobrook JP, Pauls DL. The genetics of Tourette syndrome. Neurol Clin 1997; 15:381-392.
22. Eapen V, O'Neil J, Gurling HMD, Robertson MM. Sex of parent transmission effect in Tourette's syndrome: evidence for earlier age at onset in maternally transmitted cases suggests a genomic imprinting effect. Neurology 1997; 48:934-937.
23. Lichter DG, Jackson LA, Schachter M. Clinical evidence of genomic imprinting in Tourette's syndrome. Neurology 1995; 45:924-928.
24. Caron C, Brassard A, Mërette C. Genomic imprinting in Tourette's syndrome [letter]. Neurology 1997; 49:636-638.
25. Lichter D, Jackson LA, Schachter M. Genomic imprinting in Tourette's syndrome: reply from the authors. Neurology 1997; 49:638.
26. Hebebrand J, Klug B, Fimmers R, Seuchter SA, Wettke-Schafer R, Deget F, et al. Rates for tic disorders and obsessive-complusive symptomatology in families of children and adolescents with Gilles de la Tourette syndrome. J Psychiatric Res 1997; 31:519-530. A family study of 87 Tourette syndrome patients showing lower familial rates for chronic simple tics and OCD than previous reports, casting doubts on current phenotype definition.
27. Brett PM, Curits D, Robertson MM, Gurling HMD. Neuroreceptor subunit genes and the genetic susceptibility to Gilles de la Tourette syndrome. Biol Psychiatry 1997; 42:941-947.
28. 5 receptor gene and Gilles de la Tourette syndrome. Am J Med Genet 1997; 74:58-61.
29. 4 receptor locus and Tourette syndrome by the transmission-disequilibrium test. Am J Hum Genet 1996; 59:644-652.
30. 4 receptor locus and Tourette syndrome. Am J Hum Genet 1997; 61:239-241.
31. Comings DE, Gade R, Wu S, Chiu C, Dietz G, Muhleman D, et al. Studies of the potential role of the dopamine D1 receptor gene in addicitve behaviours. Molec Psychiatry 1997; 2:44-56.
32. Cruz C, Camarena B, Kink N, Paez F, Sidenberg D, Ramonde la Fuente J, Nicolini H. Increased prevalence of the seven-repeat variant of the dopamine D4 receptor gene in patients with obsessive-compulsive disorder with tics. Neurosci Letters 1997; 231:1-4.
33. Palumbo D, Maughan A, Kurlan R. Hypothesis III: Tourette syndrome is only one of several causes of a developmental basal ganglia syndrome. Arch Neurol 1997; 54:475-483. A hypothesis of a heterogeneous aetiology converging on the basal ganglia.
34. Brito GNO. A neurobiological model for Tourette syndrome centered on the nucleus accumbens. Med Hypothesis 1997; 49:133-142.
35. Weeks RA, Turjanski N, Brooks DJ. Tourette's syndrome: a disorder of cingulate and orbitofrontal function. Q J Med 1996; 89:401-408.
36. Ziemann U, Paulus W, Rothenberger A. Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation. Am J Psychiatry 1997; 154:1277-1284.
37. Joghannes S, Weber A, Müller-Vahl KR, Kolbe H, Dengler R, Münte TF. Event-related brain potentials show changed attentional mechanisms in Gilles de la Tourette syndrome. Eur J Neurology 1997; 4:152-161.
38. Yordanova J, Dumais-Huber C, Rothenberger A, Woerner W. Frontocortical activity in children with comorbidity of tic disorder and attention-deficit hyperactivity disorder. Biol Psychiatry 1997; 41:585-594.
39. Van Woerkom TCAM, Fortgens C, Van de Wetering BJM. Contingent negative variation in adults with Gilles de la Tourette syndrome. J Neurology Neurosurg Psychiatry 1985; 51:630-634.
40. Narita AS, Shawkat FS, Lask B, Taylor DSI, Harris CM. Eye movement abnormalities in a case of Tourette syndrome. Dev Med Child Neurol 1997; 39:270-273.
41. Straube A, Mennicken J-B, Riedel M, Eggert T, Müller N. Saccades in Gilles de la Tourette syndrome. Mov Disord 1997; 12:536-546. A study of saccadic eye movements in 10 TS patients showing abnormalities of antisaccades with an implication of basal ganglia dysfunction.
42. Baumgardner TL, Singer HS, Denckla MB, Rubin MA, Abrams BA, Colli MJ, Reiss AL. Corpus callosum morphology in children with Tourette syndrome and attention deficit hyperactivity disorder. Neurology 1996; 47:477-482.
43. Peterson BS, Leckmanm J, Duncan J. Corpus callosum morphology from magnetic resonance images in Tourette's syndrome. Psychiatry Res 1994; 55:85-99.
44. Moriarty J, Varma AR, Stevens J, Fish M, Trimble MR, Robertson MM. A volumetric MRI study of Gilles de la Tourette's syndrome. Neurology 1997; 49:419-415.
45. Klieger PS, Fett KA, Dimitsopulos T, Kurlan R. Asymmetry of basal ganglia perfusion in Tourette's syndrome shown by Technetium-99m-HMPAO SPECT. J Nucl Med 1997; 38:188-191.
46. Riddle M, Rasmussen A, Woods S. Hoffer PB. SPECT imaging of cerebral blood flow in Tourette's syndrome. Adv Neurol 1992; 58:207-211.
47. Sieg K. Buckingham D, Gaffney G, Presotn DF, Sieg KG. Technetium-99m-HMPAO SPECT imaging of Gilles de la Tourette's syndrome. Clin Nucl Med 1993; 18:255.
48. Georgiou N, Bradshaw JL, Philips JG, Cunnington R, Rogers M. Functional asymmetries in the movement kinematics of patients with Tourette's syndrome. J Neurology Neurosurg Psychiatry 1997; 63:188-195. Clinical evidence of anomalous lateralization of hand movements showing a reduction in asymmetry of accurate control, complementing the reductions in asymmetry seen in imaging studies.
49. Moriarty J, Eapen V, Costa DC, Gacinovic, Trimble M, Ell PJ, Robertson MM. HMPAO SPECT does not distinguish obsessive-compulsive and tic syndromes in families multiply affected with Gilles de la Tourette syndrome. Psychol Med 1997; 27:737-740.
50. Eidelberg D, Moeller JR, Antonini A, Kazumata K, Dhawan V, Budman C, Feigin A. The metabolic anatomy of Tourette's syndrome. Neurology 1997; 48:927-934. An FDG PET study of 10 individuals with Tourette syndrome using a covariate method to identify related regional patterns of metabolic abnomality in distributed circuitry, implicating a specific network of decreased metabolism in basal ganglia-thalamocortical projection systems.
51. Pantoni L, Poggesi L, Repice A, Inzitari D. Disappearance of motor tics after Wemicke's encephalopathy in a patient with Tourette's syndrome. Neurology 1997; 48:381-383. A lesional case study documenting remission of Tourette syndrome in association with a dorsal midbrain abnormality.
52. Peterson BS, Skudlarski P, Anderson AW, Zhang H, Gatenby JC, Lacadie CM, et al. A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. Arch Gen Psychiatry 1998; 54:326-333. The first use of this technique in 22 Tourette syndrome patients examined tic suppression, finding similar subcortical changes to previous PET/SPECT blood flow studies which compared Tourette syndrome to normals, illustrating the difficulty of applying functional imaging where it is difficult to separate 'state' and 'trait'.
53. Singer HS. Neurobiology of Tourette syndrome. Neurol Clin 1997; 15:357-379.
54. Wolf SS, Jines DW, Knable MB, Gorey JG, Lee KS, Hyde TM, et al. Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 1996; 273:1225-1227.
55. Wong DF, Singer HS, Brandt J, Shaya E, Chen C, Brown J, et al. D2-like dopamine receptor density in Tourette syndrome measured by PET. J Nucl Med 1997; 38:1243-1247.
56. Lees AJ. Georges Gilles de la Tourette: the man and his times. Rev Neurol 1986; 142:808-816.
57. Mercadante MT, do Roasario Campos MC, Marques-Dias MJ, Miguel EC, Leckman J. Vocal tics in Sydenham's chorea [letter]. J Am Acad Child Adolesc Psychiatry 1997; 36:305. Further evidence of a clinical spectrum between Tourette syndrome and Sydenham's chorea, with eight out of 10 cases showing vocal tics and, as expected, a high incidence of OCD.
58. Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1996; 155:264-271. A clinical study further delineating and defining the association of Tourette syndrome and group A β-haemolytic streptococcal infection.
59. Kiessling LS, Marcotte AC, Culpepper L. Antineuronal antibodies in movement disorders. Pediatrics 1993; 92:39-43.
60. Laurino JP, Hallet J, Kiessling LS, Benson M, Pelletier T, Kuhn C. An immunoassay for anti-neuronal antibodies associated with involuntary repetitive movement disorders. Ann Clin Lab Sci 1997; 27:230-235. Further laboratory evidence of autoimmunity in PANDAS, using binding to an enriched neuroblastoma membrane preparation showing both sensitivity and specificity for Tourette syndrome.
61. Swedo SE, Leonard HL, Mittleman BB, Allen AJ, Rapoport JL, Dow SP, et al. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry 1997; 154:110-112. Evidence that Tourette syndrome and OCD in the context of PANDAS (24 patients) is associated with an immunological marker for susceptibility to rheumatic fever.
62. Murphy TK, Goodman WK, Fudge MW, Williams RC, Ayoub EM, Dalal M, et al. B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome. Am J Psychiatry 1997; 154:402-407. Independent corroboration of the above observation in 31 patients with OCD with or without tics, who in this study were not selected to fulfil criteria for PANDAS.
63. Riedel M, Straube A, Schwartz MJ, Wilske B, Müller N. Lyme disease presenting as Tourette's syndrome [letter]. Lancet 1998; 351:418-419. An interesting case report in which immunological evidence for Lyme disease appeared to be aetiologically related to Tourette syndrome, as both remitted after antibiotic treatment.
64. Budman CL, Kerjakovic M, Bruun R. Viral infection and tic exacerbation [letter]. J Am Acad Child Adolesc Psychiatry 1997; 36:162.
65. Kurlan R. The pathogenesis of Tourette's syndrome. Arch Neurol 1992; 49:874-876.
66. Peterson AI, Azrin NH. An evaluation of behavioral treatments for Tourette syndrome. Behav Res Therapy 1992; 30:167-174.
67. March JS. Cognitive-behavioral psychotherapy for children and adolescents with OCD: a review and recommendations for treatment. Am Acad Child Adolesc Psychiatry 1995, 34:7-18.
68. Rickards H, Hartley N, Robertson MM. Seignot's paper on the treatment of Tourette's syndrome with haloperidol. Hist Psychiatry 1997; viii:433-436.
69. 2 receptors.
70. Robertson MM, Scull DA, Eapen V, Trimble MR. Risperidone in the treatment of Tourette syndrome: a retrospective case note study. J Psychopharmacol 1996; 10:317-320.
71. Stein DJ, Bouwer C, Hawkridge S, Emsley RA. Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders. J Clin Psychiatry 1997; 58:119-122.
72. Roan AB, Malone RP. Tics with risperidone withdrawal [letter], J Am Acad Child Adolesc Psychiatry 1997; 36:162-163.
73. Bhadrinah BR. Olanzepine in Tourette syndrome [letter]. Br J Psychiatry 1998; 172:366.
74. Schmider J, Hoff P. Clozapine in Tourette's syndrome. J Clin Psychopharmacol 1998; 18:88-89.
75. Caine ED, Polinsky RJ, Kartzinel R, Ebert MH. The trial use of clozapine for abnormal involuntary movement disorders. Am J Psychiat 1979; 136:317-320.
76. Jankovic J, Beach J. Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997; 48:358-362. A description of the authors' experience with tetrabenazine in various movement disorders over the last 15 years, including 47 patients with Tourette syndrome of whom over half showed a marked improvement.
77. Griesemer DA. Pergolide in the management of Tourette syndrome. J Child Neurol 1997; 12:402-403.
78. Lipinski JF, Sallee FR, Jackson C, Sethuraman G. Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide. Mov Disord 1997; 12:402-107. Patients aged 7-19 years received pergolide for 6 weeks with 75% showing a significant improvement in tics. Improvement was correlated with the presence of restless legs syndrome.
79. Voderholzer U, Muller N, Haag C, Riemann D, Straube A. Periodic limb movements during sleep are a frequent finding in patients with Gilles de la Tourette syndrome. J Neurol 1997; 244:521-526.
80. Kumar R, Lang AE. Coexistence of tics and parkinsonism: evidence for non-dopaminergic mechanisms in tic pathogenesis. Neurology 1997; 49:1699-1701.
81. Chappell PB, Riddle MA, Scahill L, Lynch KA, Scultz R, Arnsten A, et al. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience. J Am Acad Adolesc Child Psychiatry 1995; 34:1140-1146.
82. Cohn LM, Caliendo GC. Guanfacine use in children with attention deficit hyperactivity disorder [letter]. Ann Pharmacol 1997; 31:918-919.
83. Nolan EE, Gadow KD. Children with ADHD and tic disorder and their classmates: behavioral normalization with methylphenidate. J Am Acad Child Adolesc Psychiatry 1997; 36:597-604.
84. Castellanos FX, Giedd JN, Elia J, Marsh WL, Ritchie GF, Hamburger SD. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose. J Am Acad Child Adolesc Psychiatry 1997; 36:589-596. A double-blind placebo-controlled crossover study in 20 patients over 9 weeks, comparing methylphenidate and dextroamphetamine, showing improvement in ADHD but a reversible worsening of tics in a minority of cases.
85. Abwender DA, Como PG, Kurlan R, Parry K, Fett KA, Cui L, et al. School problems in Tourettes syndrome. Arch Neurol 1996; 53:509-511.
86. de Groot CM, Yeates KO, Baker GB, Bornstein RA. Impaired neuropsychological functioning in Tourette's syndrome subjects with co-occuring obsessive-compulsive and attention deficit symptoms. J Neuropschiatry Clin Neursci 1997; 9:267-272.
87. Scahill L, Riddle MA, King RA, Hardin MT, Rasmussen A, Makuch RW, Leckman JF. Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: a double-blind placebo-controlled study. J Am Acad Adolesc Child Psychiatry 1997; 7:75-85.
88. Dursun SM, Reveley MA. Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: an open study. Psychological Med 1997; 27:483-487.
89. Shapira NA, McConville BJ, Pagnucco ML, Norman AB, Keck PE. Novel use of tramadol hydrochloride in the treatment of Tourette's syndrome [letter]. J Clin Psychiatry 1997; 58:174-175.
90. Mullervahl KR, Kolbe H, Dengler R. Gilles de la Tourette syndrome, influence of nicotine, alcohol and marijuana on the clinical symptoms [in German]. Nervenarzt 1997; 68:985-989. A study documenting 11 patients who reported improvement with marijuana using a questionnaire; this has yet to be confirmed in a medically supervised prospective study.
91. Rausch S, Baer L, Cosgrove GR, Jenike MA. Neurosurgical treatment of Tourette's syndrome: a critical review. Compr Psychiatry 1995; 36:141-156.
92. Bondarenko ES, Iur'eva EA, Zykov VP, Alekseeva NV. The laser therapy in children with Tourette's syndrome [in Russian]. Zhumal Nevropatologii i Psikhiatrii Imeni S-S-Korsakova 1997; 97:29-32.
93. Saghir AN, Rickards H, Pall HS. Postprandial changes in superoxide dismutase activity in subjects with Gilles de la Tourette syndrome and controls. Exp Neurol 1997; 144:420-422.
94. Sandyk R. Reversal of a visuoconstructional disorder by weak electromagnetic fields in a child with Tourette's syndrome. Int J Neurosci 1997; 90:159-167